FindTrial
Sign In

Prospective evaluation of novel 22G FNA needle for pancreatic lesions

Prospective evaluation of novel 22G FNA needle for pancreatic lesions - Prospective evaluation of novel 22G FNA needle for pancreatic lesions

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025708
Enrollment
50
Registered
2017-01-17
Start date
2017-01-17
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumors

Interventions

EUS-FNA

Sponsors

Osaka Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Contraindication of EUS-FNA

Design outcomes

Primary

MeasureTime frame
Diagnostic yield—

Countries

Japan

Contacts

Public ContactTakeshi Ogura

Osaka Medical College 2nd Department of Internal Medicine,

oguratakeshi0411@yahoo.co.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026